Allogeneic serum-based eye drops may give better results than autologous drops in Sjögren's syndrome dry eye
Authors:
- 23 August 2024
- journal article
- research article
- Published by Elsevier in Transfusion and Apheresis Science
- Vol. 63 (5) , 103991
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Correlation between serum cytokine levels and the effect of allogeneic serum-based eye dropsTransfusion and Apheresis Science, 2024
- Patient-reported outcome measures for a large cohort of serum eye drops recipients in the UKEye, 2021
- Allogeneic and autologous serum eye drops: a pilot double‐blind randomized crossover trialActa Ophthalmologica, 2021
- Use of Autologous Serum Tears for the Treatment of Ocular Surface Disease From Patients With Systemic Autoimmune DiseasesAmerican Journal of Ophthalmology, 2018
- Blood derived eye drops for the treatment of cornea and ocular surface diseasesTransfusion and Apheresis Science, 2017
- Improving the anti‐inflammatory effect of serum eye drops using allogeneic serum permissive for regulatory T cell inductionActa Ophthalmologica, 2015
- Comparison of Clinical Efficacies of Autologous Serum Eye Drops in Patients With Primary and Secondary Sjögren SyndromeCornea, 2014
- Epitheliotrophe Kapazität von Serum-Augentropfen gesunder versus immunsupprimierter Patienten mit rheumatoider ArthritisKlinische Monatsblätter für Augenheilkunde, 2008
- Comparison of Autologous Serum and Umbilical Cord Serum Eye Drops for Dry Eye SyndromeAmerican Journal of Ophthalmology, 2007
- Beneficial Effect of Artificial Tears Made with Autologous Serum in Patients with Keratoconjunctivitis SiccaArthritis & Rheumatism, 1984